Anti-CKAP2 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. This is an antibody which specifically binds to TMAP (tumor associated microtubule associated
protein)/CKAP2 (cytoskeleton associated protein 2), used for diagnosing cancer prognosis.